Preliminary research published in Nature suggests that COVID-19 vaccines, particularly Pfizer and Moderna, may offer unexpected benefits for cancer patients. People with advanced lung or skin cancer who received the vaccine within 100 days of starting immunotherapy lived significantly longer. Researchers found that the mRNA in the vaccines might enhance the immune system’s response to cancer treatments, independent of any virus-related effects.
Trending
- How the Trump-Xi Meeting Eased a Major Trade War
- ‘Win for passengers’ as Virgin clears first step to run Channel Tunnel trains to rival Eurostar | Money News
- Moving house? Check if your energy supplier owes you money
- Apple and Amazon defy expectations with latest results | Science, Climate & Tech News
- Firms develop new tech to electrify trains
- Blowen, drinken en brutaal? Pubercoach tipt: 'Negatief gedrag betekent dat jij als ouder aan zet bent'
- Flu season hits five weeks early
- Paris and Marseille drop points again in Ligue 1
